Fusidic acid resistance in Staphylococcus aureus
Open Access
- 1 January 2004
- journal article
- review article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 89 (1) , 74-77
- https://doi.org/10.1136/adc.2003.019695
Abstract
This review summarises current knowledge of the microbiological and clinical aspects of fusidic acid resistance in Staphylococcus aureus, and makes recommendations about fusidic acid prescribing and further research.Keywords
This publication has 40 references indexed in Scilit:
- Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribingJournal of Antimicrobial Chemotherapy, 2003
- Genetic characterization of the fusidic acid and cadmium resistance determinants of Staphylococcus aureus plasmid pUB101.Journal of Antimicrobial Chemotherapy, 2002
- Fusidic-acid use and resistanceThe Lancet, 2002
- Cost-Effectiveness of Erythromycin Versus Mupirocin for the Treatment of Impetigo in ChildrenPediatrics, 1992
- A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigoJournal of the American Academy of Dermatology, 1990
- Topical antibiotic therapy: current status and future prospects.1990
- The antibiotic sensitivity of bacteria isolated from the blood of patients in St Thomas' Hospital, 1969-1988Journal of Antimicrobial Chemotherapy, 1990
- Fusidic acid in staphylococcal bone and joint infectionJournal of Antimicrobial Chemotherapy, 1990
- Staphylococcal bacteraemia and endocarditis and fusidic acidJournal of Antimicrobial Chemotherapy, 1990
- The antimicrobial activity of fusidic acidJournal of Antimicrobial Chemotherapy, 1990